Lv1
40 积分 2026-02-05 加入
[Influence of Shenfu Injection on the quality of life of lung cancer patients receiving chemotherapy]
1个月前
已关闭
Pyruvate kinase M2 activation reprograms mitochondria in CD8 T cells, enhancing effector functions and efficacy of anti-PD1 therapy
1个月前
已完结
Targeted Inhibition of Tumor Extracellular Vesicle Secretion Improving the Anti‐Tumor Immunity of Lymph Node‐Targeted Vaccines
1个月前
已完结
ETV7 limits the antiviral and antitumor efficacy of CD8+ T cells by diverting their fate toward exhaustion
1个月前
已完结
First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial
1个月前
已完结
1. Lymphocytes
1个月前
已完结
T cell exclusion, immune privilege, and the tumor microenvironment
1个月前
已完结
Dynamics and specificities of T cells in cancer immunotherapy
2个月前
已完结
Non-small-cell lung cancer
2个月前
已完结